UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

British journal of cancer, 2007-04, Vol.96 (8), p.1166-1169

2007

Volltextzugriff (PDF)

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

European journal of cancer (1990), 2017-10, Vol.84, p.239-249

2017

Volltextzugriff (PDF)

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

British journal of cancer, 2006-09, Vol.95 (6), p.705-709

2006

Volltextzugriff (PDF)

Liver adenomatosis : Reappraisal, diagnosis, and surgical management: Eight new cases and review of the literature

Annals of surgery, 2000, Vol.231 (1), p.74-81

2000

Volltextzugriff (PDF)

Withholding Anti-EGFR: Impact on outcome of RAS wild-type metastatic colorectal tumours (WAIT OR ACT): A multicentric AGEO study

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii163

2018

Volltextzugriff (PDF)

Is pathological complete response after a trimodality therapy, a predictive factor of long-term survival in locally-advanced esophageal cancer? Results of a retrospective monocentric study

Journal of visceral surgery, 2018-10, Vol.155 (5), p.365-374

2018

Volltextzugriff (PDF)

Has adherence to treatment guidelines for mid/low rectal cancer affected the management of patients? A monocentric study of 604 consecutive patients

Journal of visceral surgery, 2019-09, Vol.156 (4), p.281-290

2019

Volltextzugriff (PDF)

Sorafenib (Soraf) and irinotecan (Iri) combination for pretreated RAS-mutated metastatic colorectal cancer (mCRC) patients: a multicentre randomized phase II trial (NEXIRI 2-PRODIGE 27)

Annals of oncology, 2016-10, Vol.27, p.vi154-vi154

2016

Volltextzugriff (PDF)

Prévention des nausées et vomissements dus aux cytotoxiques : réalisation d'un arbre décisionnel et place de l'aprépitant (Emend®)

Journal de pharmacie clinique, 2006-04, Vol.25 (2), p.79-85

2006

Volltextzugriff (PDF)

LBA-04The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii141-ii141

2016

Volltextzugriff (PDF)

Chimioradiothérapie concomitante par folfox–cetuximab dans les carcinomes du cardia et de l’œsophage de stade III : résultats définitifs de l’étude de phase II Erafox du groupe Gercor

Cancer radiothérapie, 2011-10, Vol.15 (6), p.566-566

2011

Volltextzugriff (PDF)

O025 Incidence des greffes tumorales sur l’orifice de sonde de gastrostomie en cas de cancer ORL ou oesophagien

Nutrition clinique et métabolisme, 2007-11, Vol.21, p.43-44

2007

Volltextzugriff (PDF)

LBA-04 The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Annals of oncology, 2016-06, Vol.27, p.ii141

2016

Volltextzugriff (PDF)

564PBRAF-mutated colorectal metastases: What is the benefit of liver surgery? Results from a cohort of 91 patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

485PWithholding Anti-EGFR: Impact on outcome of RAS wild-type metastatic colorectal tumours (WAIT OR ACT): A multicentric AGEO study

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Weekly cisplatin/irinotecan and radiotherapy (RT) in patients with locally advanced esophageal cancer : multicenter FFCD phase II trial

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4060-4060

2005

Volltextzugriff (PDF)

Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol

Therapie, 2005-09, Vol.60 (5), p.499

2005

Volltextzugriff (PDF)

Liver adenomatosis

Gastroenterology (New York, N.Y. 1943), 1998-04, Vol.114, p.A1231-A1231

1998

Volltextzugriff (PDF)

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

The New England journal of medicine, 2023-05, Vol.388 (18), p.1657-1667

2023

Volltextzugriff (PDF)

Strontium Ranelate Increases Cartilage Matrix Formation

Journal of bone and mineral research, 2001-02, Vol.16 (2), p.299-308

2001

Volltextzugriff (PDF)

BRAF-mutated colorectal metastases: What is the benefit of liver surgery? Results from a cohort of 91 patients

Annals of oncology, 2019-10, Vol.30, p.v213

2019

Volltextzugriff (PDF)

564P - BRAF-mutated colorectal metastases: What is the benefit of liver surgery? Results from a cohort of 91 patients

Annals of oncology, 2019-10, Vol.30, p.v213-v213

2019

Volltextzugriff (PDF)

Chimiothérapie par oxaliplatine normalisée à la quantité de masse maigre pour des cancers du côlon de stade III traités en adjuvant : impact sur les neurotoxicités à partir d’une étude randomisée multicentrique de phase II (LEANOX)

Nutrition clinique et métabolisme, 2023-05, Vol.37 (2), p.e57-e58

2023

Volltextzugriff (PDF)

Féminisation de la patientèle en oncologie thoracique et vécu des soignantes : recherche exploratoire

Revue des maladies respiratoires, 2020-02, Vol.37 (2), p.123-133

2020

Volltextzugriff (PDF)

ReCLAIM v2.0: a spreadsheet tool for calculating doses and soil/water radionuclide screening levels for assessment of radioactively contaminated land

Journal of radiological protection, 2007-03, Vol.27 (1), p.87-93

2007

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(38)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(10)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Chemotherapy
(4)
Female
(4)
Male
(4)
Tumors
(4)
Adult
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Cancer
(3)
Cisplatin - Adverse Effects
(3)
Life Sciences
(3)
Middle Aged
(3)
Oncology
(3)
Surgery
(3)
Survival
(3)
Treatment Outcome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

Liver adenomatosis : Reappraisal, diagnosis, and surgical management: Eight new cases and review of the literature

Withholding Anti-EGFR: Impact on outcome of RAS wild-type metastatic colorectal tumours (WAIT OR ACT): A multicentric AGEO study

Is pathological complete response after a trimodality therapy, a predictive factor of long-term survival in locally-advanced esophageal cancer? Results of a retrospective monocentric study

Has adherence to treatment guidelines for mid/low rectal cancer affected the management of patients? A monocentric study of 604 consecutive patients

Sorafenib (Soraf) and irinotecan (Iri) combination for pretreated RAS-mutated metastatic colorectal cancer (mCRC) patients: a multicentre randomized phase II trial (NEXIRI 2-PRODIGE 27)

Prévention des nausées et vomissements dus aux cytotoxiques : réalisation d'un arbre décisionnel et place de l'aprépitant (Emend®)

LBA-04The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Chimioradiothérapie concomitante par folfox–cetuximab dans les carcinomes du cardia et de l’œsophage de stade III : résultats définitifs de l’étude de phase II Erafox du groupe Gercor

O025 Incidence des greffes tumorales sur l’orifice de sonde de gastrostomie en cas de cancer ORL ou oesophagien

LBA-04 The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

564PBRAF-mutated colorectal metastases: What is the benefit of liver surgery? Results from a cohort of 91 patients

485PWithholding Anti-EGFR: Impact on outcome of RAS wild-type metastatic colorectal tumours (WAIT OR ACT): A multicentric AGEO study

Weekly cisplatin/irinotecan and radiotherapy (RT) in patients with locally advanced esophageal cancer : multicenter FFCD phase II trial

Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol

Liver adenomatosis

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

Strontium Ranelate Increases Cartilage Matrix Formation

BRAF-mutated colorectal metastases: What is the benefit of liver surgery? Results from a cohort of 91 patients

564P - BRAF-mutated colorectal metastases: What is the benefit of liver surgery? Results from a cohort of 91 patients

Chimiothérapie par oxaliplatine normalisée à la quantité de masse maigre pour des cancers du côlon de stade III traités en adjuvant : impact sur les neurotoxicités à partir d’une étude randomisée multicentrique de phase II (LEANOX)

Féminisation de la patientèle en oncologie thoracique et vécu des soignantes : recherche exploratoire

ReCLAIM v2.0: a spreadsheet tool for calculating doses and soil/water radionuclide screening levels for assessment of radioactively contaminated land

Aktive Filter

Suchergebnisse filtern